KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 152 filers reported holding KURA ONCOLOGY INC in Q1 2022. The put-call ratio across all filers is 0.17 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,403,088 | -14.7% | 702,093 | -1.0% | 4.29% | -15.6% |
| Q2 2023 | $7,502,468 | +8.5% | 709,118 | +25.5% | 5.08% | -0.2% |
| Q1 2023 | $6,913,093 | +11.1% | 565,257 | +12.7% | 5.09% | +33.0% |
| Q4 2022 | $6,223,615 | -15.1% | 501,500 | -6.5% | 3.83% | +21.4% |
| Q3 2022 | $7,329,000 | -25.5% | 536,500 | 0.0% | 3.16% | -42.4% |
| Q2 2022 | $9,834,000 | +29.0% | 536,500 | +13.2% | 5.48% | +53.9% |
| Q1 2022 | $7,621,000 | +86.5% | 473,969 | +62.4% | 3.56% | +107.4% |
| Q4 2021 | $4,086,000 | -25.3% | 291,884 | 0.0% | 1.72% | -11.0% |
| Q3 2021 | $5,467,000 | -25.8% | 291,884 | -17.4% | 1.93% | -34.5% |
| Q2 2021 | $7,368,000 | -51.4% | 353,398 | -34.2% | 2.94% | -46.2% |
| Q1 2021 | $15,176,000 | -27.1% | 536,820 | -15.8% | 5.47% | -3.4% |
| Q4 2020 | $20,821,000 | -30.2% | 637,500 | -34.5% | 5.67% | -30.0% |
| Q3 2020 | $29,813,000 | +109.6% | 973,000 | +11.5% | 8.10% | +97.0% |
| Q2 2020 | $14,222,000 | +621.9% | 872,500 | +340.7% | 4.11% | +330.3% |
| Q1 2020 | $1,970,000 | -40.3% | 198,000 | -17.5% | 0.96% | +16.9% |
| Q4 2019 | $3,300,000 | +129.0% | 240,000 | +152.6% | 0.82% | -21.4% |
| Q3 2019 | $1,441,000 | – | 95,000 | – | 1.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 3,766,852 | $57,633,000 | 6.49% |
| GREAT POINT PARTNERS LLC | 2,197,283 | $33,618,000 | 5.74% |
| Sio Capital Management, LLC | 392,027 | $5,998,000 | 3.38% |
| BVF INC/IL | 1,353,846 | $20,714,000 | 2.50% |
| Boxer Capital, LLC | 844,789 | $12,925,000 | 2.36% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 89,673 | $1,372,000 | 2.18% |
| Minerva Advisors LLC | 170,921 | $2,607,000 | 1.41% |
| NEXTHERA CAPITAL LP | 445,550 | $6,817,000 | 1.26% |
| DAFNA Capital Management LLC | 117,281 | $1,794,000 | 0.97% |
| PFM Health Sciences, LP | 1,752,124 | $26,807,000 | 0.64% |